Deepak Chemtex Ltd
Incorporated in 1997, Deepak Chemtex manufactures colourants used in food, pharmaceuticals, cosmetics, confectionery,
feeds and ink jet inks[1]
- Market Cap ₹ 101 Cr.
- Current Price ₹ 93.1
- High / Low ₹ 126 / 67.0
- Stock P/E 9.91
- Book Value ₹ 64.1
- Dividend Yield 0.00 %
- ROCE 19.5 %
- ROE 14.3 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.4.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 54 | 46 | 49 | 79 | 67 | 77 | |
| Sales growth | -14% | +6% | +61% | -15% | +7% | |
| 48 | 39 | 41 | 63 | 56 | 64 | |
| Operating Profit | 6 | 8 | 8 | 17 | 11 | 12 |
| OPM % | 11% | 17% | 16% | 21% | 17% | 16% |
| 0 | 1 | 1 | 3 | 3 | 4 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 3 |
| Profit before tax | 6 | 8 | 8 | 17 | 12 | 14 |
| Tax % | 25% | 25% | 27% | 25% | 27% | |
| 4 | 6 | 6 | 13 | 8 | 10 | |
| EPS in Rs | 5.50 | 11.52 | 7.80 | 9.39 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 20% |
| Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 11 | 11 | 11 | 11 |
| Reserves | 9 | 15 | 31 | 44 | 53 | 59 |
| 2 | 1 | 2 | 1 | 1 | 3 | |
| 6 | 7 | 7 | 11 | 10 | 22 | |
| Total Liabilities | 17 | 24 | 51 | 67 | 75 | 95 |
| 3 | 4 | 8 | 13 | 17 | 20 | |
| CWIP | 0 | 0 | 0 | 0 | 6 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 14 | 19 | 43 | 54 | 52 | 67 | |
| Total Assets | 17 | 24 | 51 | 67 | 75 | 95 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 1 | 3 | 2 | 3 | 6 | |
| -1 | -2 | -4 | -16 | -8 | |
| 0 | -1 | 20 | -1 | -0 | |
| Net Cash Flow | 0 | 1 | 19 | -14 | -2 |
| Free Cash Flow | -0 | 1 | -2 | -5 | -6 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 36% | 71% | 51% | 38% | 86% |
Ratios
Consolidated / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 57 | 88 | 107 | 93 | 89 |
| Inventory Days | 21 | 54 | 82 | 82 | 176 |
| Days Payable | 37 | 54 | 51 | 47 | 68 |
| Cash Conversion Cycle | 41 | 88 | 138 | 128 | 197 |
| Working Capital Days | 42 | 81 | 109 | 124 | 168 |
| ROCE % | 58% | 28% | 34% | 19% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Export Revenue Share % ・Standalone data |
|
|||||
| HI&I Industry Segment Revenue Share % ・Standalone data |
||||||
| Top 10 Products Revenue Share % ・Standalone data |
||||||
| Actual Production Volume MT ・Standalone data |
||||||
| Capacity Utilization % ・Standalone data |
||||||
| Installed Capacity MT ・Standalone data |
||||||
| Permanent Employees count ・Standalone data |
||||||
| Product Portfolio Size count ・Standalone data |
||||||
Extracted by Screener AI
Documents
Announcements
-
Appointment of Company Secretary and Compliance Officer
- Mr. Gourav Darak appointed Company Secretary and Compliance Officer effective November 3, 2026.
- Un-Audited Financial Results Of The Company For The Half Year Ended September 30, 2026
-
Board Meeting Outcome for Meeting Held On November 03, 2026
- Board approved H1 FY27 standalone and consolidated results; consolidated profit rose to ₹624.9 lakh.
-
Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026
- Board meeting on November 3, 2026 to approve unaudited results for half year ended September 30, 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) certificate filed for Q2 FY2026; all shares remain in demat form.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
Business Overview:[1]
DCL specializes in manufacturing, refining, exporting, importing, and trading chemical products, including:
a) Inorganic Acids and Chemicals:
- Sulphuric acid, oleum, chloro-
sulphonic acid, hydrochloric acid
- Various grades of alums, pyrites,
gypsum, bauxite, alumina, and
aluminium hydroxide
- Aluminium compounds, sulphur,
zinc, copper, and magnesium
b) Sulphates and Industrial Chemicals:
- Zinc sulphate, copper sulphate,
magnesium sulphate, and other
sulphates
- Hydrogen, chlorine, and related
industrial chemicals
b) Specialized Products:
Fertilizers, pesticides, pharmaceuticals, polymers, plastics, detergents, dyes, and essences